Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05923190
Title Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Fox Chase Cancer Center - Philadelphia RECRUITING Philadelphia Pennsylvania 19111-2497 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field